
SI-BONE Inc (SIBN) Stock Forecast & Price Target
SI-BONE Inc (SIBN) Analyst Ratings
Bulls say
SI-BONE is a medical device company with strong earnings, increased guidance, and a conservative outlook. Their success is attributed to strategic partnerships, expansion opportunities, and a capital-light business model. Although there are potential risks, the company is expected to continue its strong growth through innovative products and a focus on sustainable profitability. Their current price target may have been lowered, but there is still potential for upside given their projected growth and unique approach to sacropelvic anatomy.
Bears say
SI-BONE is a medical device company in the orthopedic and spinal industry with a narrower focus on sacroiliac joint dysfunction and fusion. Despite its success in building the SI joint fusion market and expanding its product line, the company faces risks including reimbursement challenges and competition from larger players. Additionally, its single anatomical focus and rapid sales force expansion could lead to commercial missteps and lack of profitability. These factors, along with a compressed peer sector valuation, justify a negative outlook on the stock.
This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.
SI-BONE Inc (SIBN) Analyst Forecast & Price Prediction
Start investing in SI-BONE Inc (SIBN)
Order type
Buy in
Order amount
Est. shares
0 shares